Integer Holdings Corporation (ITGR)
Stock Price Chart
Key Info
| Market Cap | 2.31B |
| Revenue (ttm) | 1.20B |
| Net Income (ttm) | 73.10M |
| Shares Out | 32.83M |
| EPS (ttm) | 2.21 |
| PE Ratio | 31.82 |
| Forward PE | 23.09 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 14, 2020 |
| Last Price | $70.32 |
| Previous Close | $69.94 |
| Change ($) | 0.38 |
| Change (%) | 0.54% |
| Day's Open | 69.23 |
| Day's Range | 69.23 - 70.43 |
| Day's Volume | 65,236 |
| 52-Week Range | 46.01 - 99.95 |
More Stats
| Market Cap | 2.31B |
| Enterprise Value | 3.12B |
| Earnings Date (est) | Oct 29, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 32.83M |
| Float | 32.36M |
| EPS (basic) | 2.23 |
| EPS (diluted) | 2.21 |
| FCF / Share | 3.42 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 3.14% |
| FCF Yield | 4.86% |
| Payout Ratio | n/a |
| Shares Short | 629,041 |
| Short Ratio | 2.87 |
| Short % of Float | 2.72% |
| Beta | 1.07 |
| PE Ratio | 31.82 |
| Forward PE | 23.09 |
| P/FCF Ratio | 20.56 |
| PS Ratio | 1.93 |
| PB Ratio | 1.93 |
| Revenue | 1.20B |
| Operating Income | 122.39M |
| Net Income | 73.10M |
| Free Cash Flow | 112.36M |
| Net Cash | -810.30M |
| Net Cash / Share | -24.67 |
| Gross Margin | 29.64% |
| Operating Margin | 10.22% |
| Profit Margin | 6.10% |
| FCF Margin | 9.38% |
| ROA | 3.31% |
| ROE | 6.38% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,258 | 1,215 | 1,136 | 1,076 | 800 | 688 | 664 | 646 | 569 | 533 |
| Revenue Growth | 3.55% | 6.95% | 5.63% | 34.37% | 16.38% | 3.59% | 2.75% | 13.6% | 6.64% | - |
| Gross Profit | 355 | 363 | 354 | 338 | 235 | 231 | 219 | 202 | 180 | 174 |
| Operating Income | 158 | 156 | 126 | 92.92 | 13.15 | 75.65 | 61.34 | 25.82 | 61.70 | 68.99 |
| Net Income | 96.34 | 168 | 66.68 | 5.96 | -7.59 | 55.46 | 36.27 | -4.80 | 33.12 | 33.14 |
| Shares Outstanding | 32.63 | 32.14 | 31.40 | 30.78 | 26.36 | 24.83 | 23.99 | 23.58 | 23.26 | 23.07 |
| Earnings Per Share | 2.92 | 5.15 | 2.08 | 0.19 | -0.29 | 2.14 | 1.43 | -0.20 | 1.40 | 1.40 |
| EPS Growth | -43.3% | 147.6% | 994.74% | - | - | 49.65% | - | - | 0% | - |
| Operating Cash Flow | 165 | 167 | 149 | 106 | 12.48 | 81.28 | 56.76 | 64.83 | 89.92 | 76.89 |
| Capital Expenditures | -48.17 | -43.53 | -46.83 | -58.29 | -43.87 | -24.82 | -18.56 | -41.07 | -22.28 | -13.60 |
| Free Cash Flow | 117 | 124 | 103 | 47.25 | -31.39 | 56.45 | 38.20 | 23.76 | 67.64 | 63.28 |
| Cash & Equivalents | 13.54 | 25.57 | 37.34 | 52.12 | 82.48 | 76.82 | 35.47 | 20.28 | 36.51 | 22.88 |
| Total Debt | 859 | 926 | 1,609 | 1,730 | 1,714 | 187 | 198 | 225 | 236 | 221 |
| Net Cash / Debt | -846 | -900 | -1,572 | -1,678 | -1,632 | -110 | -162 | -205 | -199 | -198 |
| Assets | 2,353 | 2,327 | 2,848 | 2,833 | 2,982 | 955 | 891 | 890 | 881 | 777 |
| Liabilities | 1,201 | 1,266 | 1,955 | 2,107 | 2,132 | 342 | 349 | 409 | 414 | 350 |
| Book Value | 1,152 | 1,060 | 893 | 725 | 851 | 613 | 542 | 481 | 467 | 427 |
Company Profile
Company Details
| Full Name | Integer Holdings Corporation |
| Country | United States |
| Employees | 8,250 |
| CEO | Joseph William Dziedzic |
Stock Information
| Ticker Symbol | ITGR |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NYSE: ITGR |
| IPO Date | September 29, 2000 |
Description
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac and neuromodulation products, such as batteries, capacitors, filtered feedthroughs, and implantable leads; implanted medical devices, pacemakers, implantable cardioverter defibrillators, implantable cardiac pacing and defibrillation leads, and heart failure therapies, such as ventricular assist devices and cardiac resynchronization devices. In addition, the company offers rechargeable batteries and chargers, and non-rechargeable batteries; arthroscopic devices and components, including shaver blades and burrs, ablation probes, and suture anchors; and laparoscopic and general surgery products, such as harmonic scalpels, radio frequency probes, and ophthalmic surgery devices. Further, it provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.